All
- All
- CNS
- Consumer
- CRO / R&D
- Dermatology
- Diagnostics
- Hematology
- Oncology
- Vaccines
- Women's Health
Oncology
2019
Merger with HLB
$212,000,000
Strategic Advisor
Diagnostics
2018
Series D Convertible Bridge Note
Not Disclosed
Strategic Advisor
Oncology
2017
Strategic Consulting Assignment
N/A
Strategic Advisor
Women's Health
2017
Out-license of Intrarosa to AMAG Pharmaceuticals
$234,310,000
Strategic Advisor
Consumer
2017
Bridge Loan
Not Disclosed
Strategic Advisor
Women's Health
2016
Term Loan Credit Facility with CRG
$85,000,000
Strategic Advisor
Dermatology
2016
Out-license of platform technology
Not Disclosed
Strategic Advisor
Consumer
2016
Acquisition of minority stake by West Pharmaceuticals
N/A
Strategic Advisor
Oncology
2015
Out-license of Phase II drug
N/A
Strategic Advisor
Vaccines
2015
Merger with Immune Targeting Systems
N/A
Strategic Advisor
Dermatology
2015
Sale of Company
$90,000,000
Sell-side Advisor
